Tag: nasdaq:gern

July 1, 2020

8 Anti-aging Stocks in the US

It can be tough to find public anti-aging stocks to invest in, but it's certainly possible with a little time...
August 8, 2019

Geron Begins Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes

Geron (NASDAQ:GERN) has announced it has started patient screening and enrollment of its Phase 3 clinical trials to evaluate its...
December 31, 2018

Geron Announces New Board Leadership Structure

Geron Corporation (Nasdaq:GERN) today announced changes to the leadership structure of the Company’s Board of Directors. For personal reasons, effective...
December 4, 2018

5 Top NASDAQ Genetics Stocks Year-to-Date

As Q4 and 2018 come to a close, the Investing News Network profiles the five top genetics stocks on the...
November 4, 2018

5 Top Weekly NASDAQ Biotech Stocks: Aptose Leads this Week

Aptose Biosciences, Trevena, Curis, Geron and Aveo Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
October 4, 2018

5 Top NASDAQ Genetics Stocks of Q3 2018

With Q3 2018 over, we've profiled the five top NASDAQ genetics stocks year-to-date. Here's a look at what they've been...
September 27, 2018

Geron Cancels Janssen Collaboration, Share Price Drops

Geron and Johnson & Johnson’s subsidiary, Janssen Biotech, have terminated their partnership on development of a drug for two different...